Pediatric chronic intestinal pseudo-obstruction is a rare disorder characterized by a severe impairment of gastrointestinal motility leading to intestinal obstruction symptoms in the absence of mechanical causes. The diagnosis is usually clinical and diagnostic work is usually aimed to rule out mechanical obstruction and to identify any underlying diseases. Treatment is challenging and requires a multidisciplinary effort. In this manuscript we describe the youngest child successfully treated with the orally administrable, longacting, reversible anti-cholinesterase drug, pyridostigmine. Like other drugs belonging to cholinesterase inhibitors, pyridostigmine enhances gut motility by increasing acetylcholine availability in the enteric nervous system and neuro-muscular junctions. Based on the direct evidence from the reported case, we reviewed the current literature on the use of pyridostigmine in severe pediatric dysmotility focusing on intestinal pseudo-obstruction. The overall data emerged from the few published studies suggest that pyridostigmine is an effective and usually well tolerated therapeutic options for patients with intestinal pseudo-obstruction. More specifically, the main results obtained by pyridostigmine included marked reduction of abdominal distension, reduced need of parenteral nutrition, and improvement of oral feeding. The present case and review on pyridostigmine pave the way for eagerly awaited future randomized controlled studies testing the efficacy of cholinesterase inhibitors in pediatric severe gut dysmotility.

Pyridostigmine in pediatric Intestinal pseudo-obstruction. case report of a 2-year old girl and literature review / Di Nardo, Giovanni; Viscogliosi, Federica; Esposito, Francesco; Stanghellini, Vincenzo; Villa, Maria Pia; Parisi, Pasquale; Morlando, Alessia; Caló, Girolamo; De Giorgio, Roberto. - In: JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY. - ISSN 2093-0879. - 25:4(2019), pp. 508-514. [10.5056/jnm19078]

Pyridostigmine in pediatric Intestinal pseudo-obstruction. case report of a 2-year old girl and literature review

Di Nardo, Giovanni
Primo
Conceptualization
;
ESPOSITO, Francesco;Villa, Maria Pia;Parisi, Pasquale;
2019

Abstract

Pediatric chronic intestinal pseudo-obstruction is a rare disorder characterized by a severe impairment of gastrointestinal motility leading to intestinal obstruction symptoms in the absence of mechanical causes. The diagnosis is usually clinical and diagnostic work is usually aimed to rule out mechanical obstruction and to identify any underlying diseases. Treatment is challenging and requires a multidisciplinary effort. In this manuscript we describe the youngest child successfully treated with the orally administrable, longacting, reversible anti-cholinesterase drug, pyridostigmine. Like other drugs belonging to cholinesterase inhibitors, pyridostigmine enhances gut motility by increasing acetylcholine availability in the enteric nervous system and neuro-muscular junctions. Based on the direct evidence from the reported case, we reviewed the current literature on the use of pyridostigmine in severe pediatric dysmotility focusing on intestinal pseudo-obstruction. The overall data emerged from the few published studies suggest that pyridostigmine is an effective and usually well tolerated therapeutic options for patients with intestinal pseudo-obstruction. More specifically, the main results obtained by pyridostigmine included marked reduction of abdominal distension, reduced need of parenteral nutrition, and improvement of oral feeding. The present case and review on pyridostigmine pave the way for eagerly awaited future randomized controlled studies testing the efficacy of cholinesterase inhibitors in pediatric severe gut dysmotility.
2019
cholinesterase inhibitors; enteric nervous system; gastrointestinal motility; Intestinal pseudo-obstruction; pyridostigmine bromide
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Pyridostigmine in pediatric Intestinal pseudo-obstruction. case report of a 2-year old girl and literature review / Di Nardo, Giovanni; Viscogliosi, Federica; Esposito, Francesco; Stanghellini, Vincenzo; Villa, Maria Pia; Parisi, Pasquale; Morlando, Alessia; Caló, Girolamo; De Giorgio, Roberto. - In: JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY. - ISSN 2093-0879. - 25:4(2019), pp. 508-514. [10.5056/jnm19078]
File allegati a questo prodotto
File Dimensione Formato  
DiNardo_Pyridostigmine_2019.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.1 MB
Formato Adobe PDF
2.1 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1320393
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 9
social impact